These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 36376772

  • 1. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS, Mehtani R, Hasnain A, Bhatia S, Moond V, Kumar M, Kuhad V, Singh S, Agarwal S, Gupta S, Saigal S.
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [Abstract] [Full Text] [Related]

  • 2. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW.
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [Abstract] [Full Text] [Related]

  • 3. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.
    Choudhary NS, Saigal S, Thummala S, Saraf N, Rastogi A, Bhangui P, Srinivasan T, Yadav SK, Nundy S, Soin AS.
    J Clin Exp Hepatol; 2020 May; 10(5):442-447. PubMed ID: 33029052
    [Abstract] [Full Text] [Related]

  • 4. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
    Kashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, Jain A, Maliakkal B, Ryan C, Orloff M.
    J Gastrointest Surg; 2009 Aug; 13(8):1480-6. PubMed ID: 19430850
    [Abstract] [Full Text] [Related]

  • 6. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 7. Duct-to-duct Biliary Reconstruction in Living-donor Liver Transplantation for Primary Sclerosing Cholangitis: Report of a Case.
    Motomura T, Yoshizumi T, Wang H, Nagatsu A, Itoh S, Harada N, Harimoto N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.
    Transplant Proc; 2017 Jun; 49(5):1196-1198. PubMed ID: 28583556
    [Abstract] [Full Text] [Related]

  • 8. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [Abstract] [Full Text] [Related]

  • 9. Laparoscopic Living donor liver transplantation in irresectable intrahepatic cholangiocarcinoma in primary sclerosing cholangitis associated liver cirrhosis.
    Bednarsch J, Lang SA, Heise D, Strnad P, Neumann UP, Ulmer TF.
    Z Gastroenterol; 2024 Jan; 62(1):50-55. PubMed ID: 38195108
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry.
    Egawa H, Ueda Y, Ichida T, Teramukai S, Nakanuma Y, Onishi S, Tsubouchi H.
    Am J Transplant; 2011 Mar; 11(3):518-27. PubMed ID: 21219581
    [Abstract] [Full Text] [Related]

  • 11. Recurrence of primary sclerosing cholangitis after living donor liver transplantation.
    Tamura S, Sugawara Y, Kaneko J, Matsui Y, Togashi J, Makuuchi M.
    Liver Int; 2007 Feb; 27(1):86-94. PubMed ID: 17241386
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
    Heinemann M, Liwinski T, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, Heneghan MA, Lodge P, Pratschke J, Boudjema K, Paul A, Zieniewicz K, Fronek J, Mehrabi A, Acarli K, Tokat Y, Coker A, Yilmaz S, Karam V, Duvoux C, Lohse AW, Schramm C, all the other contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA).
    Am J Transplant; 2022 Feb; 22(2):626-633. PubMed ID: 34605157
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.
    Henson JB, Patel YA, King LY, Zheng J, Chow SC, Muir AJ.
    Liver Transpl; 2017 Jun; 23(6):769-780. PubMed ID: 28027592
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis - a propensity score-matched intention-to-treat analysis.
    Åberg F, Sallinen V, Tuominen S, Adam R, Karam V, Mirza D, Heneghan MA, Line PD, Bennet W, Ericzon BG, Grat M, Lodge P, Rasmussen A, Schmelzle M, Thorburn D, Fondevila C, Helanterä I, Nordin A, European Liver and Intestine Transplant Association (ELITA).
    J Hepatol; 2024 Jan; 80(1):99-108. PubMed ID: 37722533
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ, Scalera I, Slaney E, Laing RW, Gunson B, Hirschfield GM, Schlegel A, Ferguson J, Muiesan P.
    J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
    [Abstract] [Full Text] [Related]

  • 17. Endoscopic management of post-liver transplant billiary complications: A prospective study from tertiary centre in India.
    Ranjan P, Bansal RK, Mehta N, Lalwani S, Kumaran V, Sachdeva MK, Kumar M, Nundy S.
    Indian J Gastroenterol; 2016 Jan; 35(1):48-54. PubMed ID: 26873087
    [Abstract] [Full Text] [Related]

  • 18. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N, Kelly B, Soltys K, Squires JE, Vockley J, Shellmer DA, Strauss K, McKiernan P, Ganoza A, Sindhi R, Bond G, Mazariegos G, Khanna A.
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [Abstract] [Full Text] [Related]

  • 19. Recurrence of cholestatic liver disease after living donor liver transplantation.
    Tamura S, Sugawara Y, Kaneko J, Togashi J, Matsui Y, Yamashiki N, Kokudo N, Makuuchi M.
    World J Gastroenterol; 2008 Sep 07; 14(33):5105-9. PubMed ID: 18777585
    [Abstract] [Full Text] [Related]

  • 20. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
    Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF, Krom RA.
    Hepatology; 1999 Nov 07; 30(5):1121-7. PubMed ID: 10534330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.